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A comparison of the single-chain F, fragment of the antibody McPC603 (scF,) with its corresponding unlinked F, fragment has been carried out 
with 15N-edited NMR spectroscopy. The two F, fragments adopt the same structure, indicating that the linker does not perturb the folding of 
the domains. This also directly demonstrates that folding in vivo (F, fragment) and in vitro (scF, fragment) leads to the same structure. The main 
differences in the spectra of the uniformly “N-labeled scF, and F, fragments are due to signals of Gly and Ser from the linker peptide of the scF, 
fragment. The linker peptide has been mapped with NMR spectra of “N-glycine- and ‘5N-glycine/‘5N-serine-labeled scF, fragments. The 15N T, 
relaxation data indicate that the linker peptide is more flexible than the rest of the molecule. 
Nuclear magnetic resonance; Antibody; Single chain F, 
1. INTRODUCTION 
F, fragments are the smallest functional units of anti- 
body molecules that still contain the complete antigen 
binding site. They are heterodimers, comprising the var- 
iable light (VJ and the variable heavy (V,) chain of the 
whole antibody. To obtain functional F, or Fab frag- 
ments in E. coli [1,2], both chains must be co-secreted 
to the periplasm, where they fold and associate. Alter- 
natively, the two chains of the F, fragment can be linked 
by a peptide linker to give a single-chain F, fragment 
(scF,) that can be functionally secreted to the periplasm 
[3] or obtained as inclusion bodies in the cytoplasm 
[4,5]. In the latter case, the protein must be solubilized 
and refolded in vitro. 
In the present paper the F, fragment of the antibody 
McPC603 is compared to the corresponding scF, frag- 
ment, Vn-(Gly,Ser),-V,, with the aid of the “N-edited 
2D NMR spectroscopy. The linker sequence has been 
mapped by preparing 15N-glycine- and ‘5N-glycine/15N- 
serine-labeled scF, fragments. A comparison of the 
HMQC-spectra of these samples with spectra of the 
uniformly “N-labeled F, and scF, fragments has al- 
lowed the assignment of the residues belonging to the 
linker sequence of the scF, fragment. 
2. MATERIALS AND METHODS 
2.1. Expression and purification of the “N-labeled F. fragment of 
McPC603 
The expression vector used was pTACKAN which is a derivative 
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of the vector pASK30 [6], in which the lac promoter is substituted by 
the lac promoter and a kanamycin resistance is introduced. The E. coli 
strain MREBOO [7] harboring this plasmid was grown in minimal I*A 
medium [8], supplemented with ‘5N-ammonium chloride at 25’C. In- 
duction with 1 mM IPTG at OD,, = 1.8 and further growth for 3 h 
in a 50 1 fermenter esulted in 220 g cell paste. After adding 440 ml 
of BBS (0.2 M sodium borate, 0.16 M NaCI, pH 8.0), the cells were 
lysed by passing the suspension three times through a Gaulin press at 
a pressure of 250 bar. The lysate was then centrifuged at 15,000 x g 
for 30 min, and the supematant was directly applied to a phosphoryl- 
choline affinity column [9]. Bound protein was eluted with a solution 
of 5 mM PC in BBS. 20 mg of uniformly “N-labeled F, fragment was 
obtained. 
2.2. Expression and in vitro folding of the SCF, fragments 
The expression vector used in this case was pTFT74 (Freund et al., 
unpublished results), in which the scF, fragment is under control of 
the T7 promoter. The 5’-untranslated region between the conserved 
23 bp of the promoter and the start codon of the scF, fragment are 
almost identical to the wild-type gene 10 sequence of phage T7, with 
the only difference that a luc operator sequence insertion is present in 
the construct. The terminator sequence of gene IO was introduced just 
behind the coding sequence for the scF, fragment. The host strain used 
for expression was E. coli BL21(DE3) IJO], which carries the T7-RNA 
polymerase in the chromosome under the control of the lacUV5 pro- 
moter. 
A 10 litre shaking culture (37°C) using the same medium as above 
was used for the uniformly labeled sample and a 1 *A medium supple- 
mented with all amino acids [l l] (only glycine being “N labeled) was 
used in the case of the glycine-labeled sample. All amino acids were 
supplemented except serine in the glycine/serine-labeled sample (only 
glycine being 15N labeled). Cultures were induced at an 0DJ5,, = 0.4 
and growth was allowed for another 4 h. The cells were centrifuged 
at 5,000 x g for 10 min, resuspended in 100 ml of 10 mM Tris, 2 mM 
MgCI,, and lysed by a two-fold passage through a French Pressure 
Cell at 1.1 kbar. The lysate was treated first with DNase (ca. 10,000 
u) and RNase (ca. 500 u) for 30 min at 37°C and then 0.5 M EDTA 
(20 ml) and Triton X-100 (1 ml) were added, and the solution was 
stored for 30 min in an ice bath. After centrifugation at 12,000 x g for 
10 min, the pellet was washed with 0.5 M GdnCl. 0.1 M Tris, 20 mM 
EDTA, pH 6.8, once and then two more times with 0.1 M Tris, 5 mM 
EDTA, pH 6.8. 
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Fig. 1. The HMQC spectra of (A) ‘5N-uniformly-labeled F,, and (B) “N-uniformly-labeled scF, fragment. In the regions marked by rectangles 
there are additional peaks in the scF, fragment spectrum compared to the F, fragment spectrum. These peaks are due to the two C-terminal serines 
in V, and residues of the peptide linker (Gly,Ser), in the scF, fragment. 
The pellet was then solubilized in 50 ml of 5.5 M GdnCl, 0.2 M Tris, 
2 mM EDTA, 0.14 M DTE, pH 9.5 and stirred for 2 h under argon 
at room temperature. After centrifugation at 20,000 x g for 30 min, 
the supernatant was dialyzed three times against 1 1 of the same buffer 
without DTE. Renaturation was performed by diluting the solubilisate 
into 5 1 of renaturation buffer (0.8 M arginine, 0.2 M Tris, 2 mM 
EDTA, 1 mM reduced glutathione, 0.2 mM oxidized glutathione, 0.2 
mM of benzamidine hydrochloride, 0.2 mM e-amino caproic acid, 0.2 
mM phosphorylcholine, pH 9.5), allowing the solution to stand at 
10°C for 100 h. The protein was then concentrated using an Amicon 
RA2000 cell, resulting in a final volume of 300 ml solution, which was 
dialyzed against 5 1 of BBS (0.2 M sodium borate, 0.4 M NaCI) four 
times. The functional protein was further purified by affinity chroma- 
tography on phosphorylcholine as described above. The yield of a 
functional labeled protein was typically 1 mg per liter E. coli and 
GD,,o. 
2.3. NMR spectroscopy 
Protein solutions were concentrated by centrifugation in Centricon- 
10 tubes at 2,200 x g. NMR samples contained 1 mM protein, 1 mM 
phosphorylcholine, 1mM EDTA, and 30 mM potassium phosphate, 
pH 6.0 in 90% HZO/lO% D,O. The pulse sequence used for measuring 
HMQC spectra is described in [12]; the optimized delay for the coher- 
ence transfer was 4.8 ms. Presaturation on the water frequency was 
performed for 1.3 s. During acquisition, decoupling of 15N frequencies 
was achieved using the GARP pulse sequence [13] with 1 kHz field 
strength. The size of the FID matrix was 2K real x 128 complex 
points, and TPPI was used to obtain phase-sensitive spectra. In F, the 
98 
carrier frequency was set to 119.85 ppm, and in F, the carrier fre- 
quency was switched to the middle of the NH region (8 ppm) after 
presaturation. The T, measurement for the “Nglycine-labeled sample 
was carried out according to the sequence described in [14], which 
includes a modified CPMG sequence to remove relaxation caused by 
chemical-shift anisotropy. No incrementation of t, was performed; the 
relaxation delay was incremented by 7.52 ms from one experiment to 
the next one, thereby achieving twenty 1D spectra. Only the signals 
that were not overlapped in the 1D spectra were used to calculate T2 
relaxation times. The other parameters used were the same as for the 
HMQC spectra. All spectra were recorded at 300 K on a Bruker 
AMX-600 spectrometer. 
3. RESULTS AND DISCUSSION 
Fig. 1A and B show the HMQC spectra of the uni- 
formly “N-labeled F, and scF, fragments, respectively. 
The spectra of the two samples are remarkably similar 
and show only minor shifts for a few peaks except in the 
regions highlighted with rectangles in Fig. 1. The simi- 
larity suggests that there are no significant structural 
changes between the~scF, and the unlinked F, fragment. 
This finding is in agreement with our earlier measure- 
ments of antigen binding that showed no significant 
differences between the scF, and F, fragments in their 
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Fig. 2. The HMQC spectra of (A) ‘5N-glycine-labeled and (B) ‘SN-glycine/serine-labeled scF, fragment. The peaks marked with rectangles are those 
present only in the scF, and not in the F, fragment (see Fig. 1). In (A) the T, relaxation times are indicated for peaks for which T, relaxation data 
could be fitted to the exponential with a correlation coefficient larger than 95%. 
binding to antigen [3]. The peaks marked in Fig. 1 are 
only present in the scF, fragment and should therefore 
be due to the peptide linker. As expected, these addi- 
tional peaks are also present in spectra of the selectively 
labeled scF, (Fig. 2). In order to distinguish glycine 
from serine residues, the spectrum of scF, with only 
glycine residues labeled was compared to the spectrum 
of the glycine/serine-labeled scF, (Fig. 2). There are five 
peaks in Fig. 2B assigned to serines of the scF, frag- 
ment. Only three serines are present in the linker 
(Gly,Ser),. The two other signals are from the two se- 
quential serines that are at the C-terminus of the V, 
domain in F,, and are directly preceding the linker in 
scF,, thus changing their chemical environment upon 
connecting the linker. 
In the case of the glycine residues of the linker pep- 
tide, severe overlap prevents their individual assign- 
ments, and all but two residues (G2 and G3) appear in 
the bulk peak Gl (Figs. 1 and 2). In order to determine 
the number of glycine residues in this peak, we carefully 
integrated the Gl area and compared the integration 
with the average value for the two single glycine peaks 
of the linker (peaks G2 and G3 in Fig. 2A). Since there 
are two peaks from the F, in the Gl region (Fig. lA), 
which overlap with the bulk glycine peak of the SCF,, 
and assuming that these peaks are also glycines, the 
anticipated number of 10 glycine residues from scF, in 
peak Gl was obtained. 
The average volume for a single glycine cross peak of 
the linker peptide is about two times as large as the 
average volume of a single glycine residue within the 
domains of the scF, fragment. This is consistent with 
the observation of strong linker peptide residue signals 
as compared to the intra-domain residue signals in 
other T, relaxation time-dependent spectra of the scF, 
fragment (“N-edited 3D-TOCSY, HNCA-experiment, 
data not shown). In order to quantify these observa- 
tions, the “N T, relaxation times of the linker glycines 
and four intra-domain glycines were measured. It can 
be seen from Fig. 2A that the transversal relaxation 
times for the intra-domain peaks are between 15 and 3 1 
ms and that the T, for the linker glycines is three times 
longer than the longest intra-domain T, value (96 ms vs. 
31 ms). Although there may be some differences in the 
dynamical behavior of the glycine residues within the 
domains, the most dramatic difference is observed for 
the linker glycines, as compared to the intra-domain 
glycines. The long T2 relaxation time of the linker pep- 
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tide glycines clearly indicates an enhanced flexibility for 
this part of the molecule. The narrow chemical shift 
dispersion of the peptide linker residues suggests an 
almost identical chemical environment for these resi- 
dues. Also, the chemical shifts of the linker residues are 
very close to random coil values [I 51. This is further 
evidence that the linker region is unstructured. 
In conclusion, the NMR data indicate the linker to 
be a passive entity with an enhanced flexibility con- 
strained only by the distance between the two domains. 
The NMR analysis also shows that the same folding 
state is reached by the F, and scF, fragments, even 
though they were obtained by different expression sys- 
tems. The secretion, which can be carried out for either 
F, or SCF, fragments does not yield as much protein, but 
involves fewer steps. The cytoplasmic expression gives 
a large amount of insoluble scF, fragment, but the in 
vitro folding takes only 20% of the protein to the native 
state, even after a wide search of suitable conditions. 
Aggregation and formation of molecules with incorrect 
disulfide bonds seem to be the major problems during 
the refolding procedure [ 16,171, and may also limit the 
in vivo production of native antibody fragments [181. 
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